Evidence map›Paper›PMID 28592305›Full record

ArticleCancer imaging : the official publication of the International Cancer Imaging Society2017

Incremental diagnostic utility of systematic double-bed SPECT/CT for bone scintigraphy in initial staging of cancer patients.

Catherine Guezennec, Nathalie Keromnes, Philippe Robin, Ronan Abgral, David Bourhis, Solène Querellou, Romain de Laroche, Alexandra Le Duc-Pennec, Pierre-Yves Salaün, Pierre-Yves Le Roux

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Optimization ofJournal of applied clinical medical physics · 2022
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Catherine GuezennecService de Médecine Nucléaire, EA3878 (GETBO) IFR 148, CHRU de Brest, Brest, France. catherine.guezennec@chu-brest.fr.ORCID http://orcid.org/0000-0003-4871-6086
Nathalie KeromnesService de Médecine Nucléaire, EA3878 (GETBO) IFR 148, CHRU de Brest, Brest, France.
Philippe RobinService de Médecine Nucléaire, EA3878 (GETBO) IFR 148, CHRU de Brest, Brest, France.
Ronan AbgralService de Médecine Nucléaire, EA3878 (GETBO) IFR 148, CHRU de Brest, Brest, France.
David BourhisService de Médecine Nucléaire, EA3878 (GETBO) IFR 148, CHRU de Brest, Brest, France.
Solène QuerellouService de Médecine Nucléaire, EA3878 (GETBO) IFR 148, CHRU de Brest, Brest, France.
Romain de LarocheService de Médecine Nucléaire, EA3878 (GETBO) IFR 148, CHRU de Brest, Brest, France.
Alexandra Le Duc-PennecService de Médecine Nucléaire, EA3878 (GETBO) IFR 148, CHRU de Brest, Brest, France.
Pierre-Yves SalaünService de Médecine Nucléaire, EA3878 (GETBO) IFR 148, CHRU de Brest, Brest, France.
Pierre-Yves Le RouxService de Médecine Nucléaire, EA3878 (GETBO) IFR 148, CHRU de Brest, Brest, France.
Centre Hospitalier Régional Universitaire de Brest · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSPECT/CT has been shown to increase the diagnostic performance of bone scintigraphy for staging of malignancies. A systematic double-bed SPECT/CT of the trunk may allow further improvement. However, this would be balanced by higher dosimetry and longer acquisition time. The objective was to assess the incremental diagnostic utility of a systematic double-bed SPECT/CT acquisition for bone scintigraphy in initial staging of cancer patients, especially compared with the usual approach consisting in a whole body planar scan (WBS) plus one single-bed targeted SPECT/CT.

methodsOne hundred two consecutive patients referred for bone scintigraphy for initial staging of malignancy were analyzed. All patients underwent a double-bed SPECT/CT acquisition of the trunk. Images were interpreted by two nuclear medicine physicians in a 3-step procedure. Firstly, only WBS planar images were used; secondly, one additional single-bed SPECT/CT chosen based on planar images was used; finally, WBS planar and double-bed SPECT/CT images were interpreted. Lesions were classified as benign, equivocal or suspicious for metastasis. A per-lesion, per-anatomical region and per-patient analysis was performed.

resultsIn a per-lesion analysis, the number of equivocal and suspicious lesions was 91 and 241 using WBS planar images, 17 and 259 using a single-bed SPECT/CT acquisition and 11 and 269 using double-bed SPECT/CT images, respectively. In a per-patient analysis, the diagnostic conclusion was negative, equivocal or suspicious for malignancy in 35, 53 and 14 patients using WB planar images, 77, 6 and 19 patients using an additional single-bed SPECT/CT and 76, 7 and 19 using double-bed SPECT/CT images, respectively. Seventeen lesions unseen on WBS images were interpreted as suspicious (n = 12) or equivocal (n = 5) on double-bed SPECT/CT images. Six lesions unseen on "WBS + targeted single-bed SPECT/CT" were interpreted as suspicious on double-bed SPECT/CT, with no shift in the metastatic status of patients.

conclusionA systematic double-bed SPECT/CT acquisition has a limited incremental diagnostic value over an oriented single-bed SPECT/CT in terms of specificity and conclusiveness of bone scintigraphy in the initial staging of cancer patients. However, it slightly improved the sensitivity of the test by detecting unseen lesions on WBS, which may be of value for initial staging of cancer.

Indexed as

AdultAgedAged, 80 and overBone NeoplasmsFemaleHumansMaleMiddle AgedNeoplasm StagingPredictive Value of TestsSingle Photon Emission Computed Tomography Computed TomographyBone metastasisBone scintigraphyCancerSPECT/CTStaging

Identifiers

PMID28592305
PMCPMC5463363
OpenAlexW2622378933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.